| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 9,283 | 10,597 | 10,930 | 11,808 | | Cost of Revenue | (2,158) | 2,158 | (2,174) | 2,174 | | | Gross Profit | 11,441 | 8,439 | 13,104 | 9,634 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 4,855 | 387 | 4,804 | 573 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 525 | 2,253 | (719) | 719 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (2,129) | 5,799 | 9,019 | 8,342 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (754) | (6,224) | 4,725 | (14,984) | | Earnings Before Interest And Taxes | (11,417) | 16,058 | 13,744 | (6,642) | | Interest Expense | 1,661 | 364 | 3,463 | 2,461 | | Income Before Tax | (13,078) | 15,694 | 10,281 | (9,103) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 3,405 | (789) | 10,281 | (9,103) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 3,394 | (789) | 10,281 | (9,103) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $3,394 | ($789) | $10,281 | ($9,103) |
|
0.01% Nasdaq 
0.0045 (0.06%) 
Income Statement
